Professor Irfan Cicin is a senior medical oncologist who leads cancer care at İstinye University Liv Hospital Topkapı. He holds a professorship at Trakya University, where he trains the next generation of cancer specialists.

• Completed specialist oncology fellowship at Trakya University Faculty of Medicine
• Experienced in managing complex internal medicine cases alongside chemotherapy
• Served as a physician for the Turkish Air Force Command
• Former lead oncologist at Elazığ Training and Research Hospital
• Expertise covers a broad range of hard-to-treat solid tumours

Associate Professor Atakan Topcu is a leading medical oncologist at Medipol Acibadem District Hospital, specialising in neoadjuvant chemotherapy and targeted therapies for breast cancer.

• Published over 50 scientific articles focusing on treatment responses and patient prognosis
• Expert in managing cancer-related malnutrition and cachexia to support patients during intensive chemotherapy
• Serves on the editorial board of BMC Cancer, a major international medical journal
• Member of the European Society for Medical Oncology (ESMO)
• Completed a clinical observership at the University of Leicester in the United Kingdom

Associate Professor Ayse Irem Yasin is a highly qualified medical oncologist who completed a targeted international observership at Italy's Maggiore della Carita Hospital Breast Cancer Unit.

• Holds a European Society for Medical Oncology (ESMO) Board Certification
• Gained specialist clinical experience at Cleveland Clinic and Harvard Medical School
• Specialises in managing complex systemic therapies for breast and gynaecological cancers
• Academically recognised as an Associate Professor for her contributions to oncology
• Practises at Medipol Acibadem District Hospital in Istanbul

Associate Professor Muhammed Mustafa Atci is a leading medical oncologist at İstinye University Liv Hospital Topkapı, specialising in tailormade chemotherapy protocols for complex breast cancer cases.

• Expert in managing high-risk breast cancer based on BRCA genetic mutation profiles
• Specialises in adjuvant capecitabine therapy for patients with residual triple-negative breast cancer
• Published researcher on the impact of metabolic tumour volume on chemotherapy response
• Active member of the American Society of Clinical Oncology (ASCO)
• Education Coordinator for Medical Oncology at one of Turkey's major training hospitals

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.